Ascendis Pharma A/S (ASND) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Biotechnology उद्योग. कंपनी का मुख्यालय है Hellerup, Denmark. वर्तमान CEO हैं Jan Moller Mikkelsen.
ASND के पास है IPO तिथि 2015-01-28, 1,017 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Select, बाजार पूंजीकरण $15.34B.
Ascendis Pharma A/S is a biopharmaceutical company headquartered in Hellerup, Denmark, dedicated to developing innovative therapeutics for unmet medical needs. The company's commercial product, SKYTROFA, treats growth hormone deficiency in patients, while its robust pipeline includes TransCon-based therapies targeting pediatric and adult growth hormone deficiency, hypoparathyroidism, achondroplasia, and various oncology indications. Founded in 2006, Ascendis leverages its proprietary TransCon technology platform to extend the duration and improve the efficacy of therapeutic proteins across multiple disease areas.
